Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach $9.4 Billion by 2030
The global market for Next Generation Sequencing (NGS) Sample Preparation estimated at US$2.7 Billion in the year 2022, is projected to reach a revised size of US$9.4 Billion by 2030, growing at a CAGR of 17% over the analysis period 2022-2030. Reagents & Consumables, one of the segments analyzed in the report, is projected to record 19% CAGR and reach US$6.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Workstations segment is readjusted to a revised 13.8% CAGR for the next 8-year period.The U.S. Market is Estimated at $788.3 Million, While China is Forecast to Grow at 15.9% CAGR
The Next Generation Sequencing (NGS) Sample Preparation market in the U.S. is estimated at US$788.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 15.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.6% and 13.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.Select Competitors (Total 32 Featured) -
- Agilent Technologies
- Beckman Coulter (A Subsidiary of Danaher)
- Becton, Dickinson and Company
- Berry Genomics
- BGI
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Macrogen
- New England Biolabs, Inc.
- Novo Gene
- Nugen Technologies, Inc.
- Oxford Gene Technology
- Oxford Nanopore Technologies
- Pacific Biosciences of California, Inc.
- Perkinelmer, Inc.
- Qiagen N.V
- Raindance Technologies, Inc.
- Swift Biosciences Inc.
- Thermo Fisher
- WuXi AppTec
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies
- Beckman Coulter (A Subsidiary of Danaher)
- Becton, Dickinson and Company
- Berry Genomics
- BGI
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Macrogen
- New England Biolabs, Inc.
- Novo Gene
- Nugen Technologies, Inc.
- Oxford Gene Technology
- Oxford Nanopore Technologies
- Pacific Biosciences of California, Inc.
- Perkinelmer, Inc.
- Qiagen N.V
- Raindance Technologies, Inc.
- Swift Biosciences Inc.
- Thermo Fisher
- WuXi AppTec
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 88 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 2.7 Billion |
Forecasted Market Value ( USD | $ 9.4 Billion |
Compound Annual Growth Rate | 16.9% |
Regions Covered | Global |